UBS Reiterates Buy Rating on Option Care Health (OPCH)
UBS analyst AJ Rice reiterated a Buy rating and $39.00 price target on Option Care Health (NASDAQ: OPCH).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
